Main > ONCOLOGY (**) > Thyroid Cancer>MET>RET Fusion+ > TREAT.: > USA. E. RET Kinase Inh. Capsules
USA. E. RET Kinase Inh. Capsules's subsections
(*) CN Approval Date: 2022. 10.10
(*) USA Approval Date: 2020. 05.08.
Company
Company Marketing CN
Generic Name
Patent>USA Patent Numbers
RTM
RTM Web-Site
USA. E. RET Kinase Inh. Capsules's products
This section has no products